Jackson Grant Investment Advisers’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-303
Closed -$24.5K 445
2023
Q1
$24.5K Hold
303
0.01% 243
2022
Q4
$22.7K Hold
303
0.01% 244
2022
Q3
$20K Hold
303
0.01% 253
2022
Q2
$21K Hold
303
0.01% 259
2022
Q1
$23K Hold
303
0.01% 268
2021
Q4
$23K Hold
303
0.01% 228
2021
Q3
$22K Hold
303
0.01% 277
2021
Q2
$20K Hold
303
0.01% 298
2021
Q1
$23K Hold
303
0.01% 275
2020
Q4
$22K Buy
+303
New +$21.4K 0.01% 251

Other funds holding HOLX

Jackson Grant Investment Advisers's HOLX Position: Q2 2023 in Review

Jackson Grant Investment Advisers sold out of Hologic (HOLX) in Q2 2023, closing a stake of 303 shares — an estimated $24.5K sold.

Jackson Grant Investment Advisers first reported a position in HOLX in Q4 2020 and held it in 10 quarters. The position peaked at $24.5K in Q1 2023. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Jackson Grant Investment Advisers reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Jackson Grant Investment Advisers sold 303 Hologic shares in Q2 2023, an estimated $24.5K.
  • Jackson Grant Investment Advisers first reported a position in Hologic in Q4 2020 and held it in 10 quarters.
  • Jackson Grant Investment Advisers's Hologic position peaked at $24.5K in Q1 2023.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2023, filed 1 Aug 2023.